Biosimilars

Filter

Current filters:

None

Popular Filters

1 to 25 of 105 results

Merck Serono on track with pharma strategy

Merck Serono on track with pharma strategy

18-09-2014

Germany’s Merck KGaA says that its biopharmaceutical division - Merck Serono - is well on track with…

ataciceptBiosimilarsFinancialGermanyImmunologicalsMerck KGaAMerck SeronoOncologyPharmaceuticalResearchTH-302

EuropaBio calls for EMA action on labeling of biosimilars

18-09-2014

EuropaBio has published a statement giving the perspective of the health care biotechnology industry…

BiosimilarsBiotechnologyEuropeRegulation

Opportunity for emerging agents in Crohn’s disease, report finds

Opportunity for emerging agents in Crohn’s disease, report finds

18-09-2014

New research from Decision Resources Group has found that only a small proportion of patients with Crohn's…

Anti-Arthritics/RheumaticsBiosimilarsEntyvioHumiraPharmaceuticalRemicadeResearchStelaraUSAXeljanz

Biosimilars market could make vast cost savings - but only if it is sustainable: report

Biosimilars market could make vast cost savings - but only if it is sustainable: report

15-09-2014

Biosimilars stand to represent a major opportunity for cost saving across Europe as long as it becomes…

BiosimilarBiosimilarsDrugsEuropeEuropean Biosimilars GroupMarkets & Marketing

USA’s generic pharma savings reach highest-ever watermark

USA’s generic pharma savings reach highest-ever watermark

15-09-2014

The US Generic Pharmaceutical Association (GPhA) last week released a report showing that generic drugs…

BiosimilarsFinancialGenericsMarkets & MarketingUSA

Green Cross Neulapeg biosimilar approved in South Korea

28-08-2014

South Korea’s Green Cross says that the country’s Ministry of Food and Drug Safety has granted marketing…

AmgenAsia-PacificBiosimilarsBiotechnologyGreen CrossNeulapegNeulastaOncologyRegulation

Brazilian antitrust agency approves Bionovis and Merck's partnership deal

Brazilian antitrust agency approves Bionovis and Merck's partnership deal

28-08-2014

The General Superintendent of the Brazilian Antitrust Agency (CADE) approved the agreement between the…

BionovisBiosimilarsBrazilLicensingMerck KGaAPharmaceuticalResearch

China monoclonal antibody research forecast to increase

China monoclonal antibody research forecast to increase

28-08-2014

Several Chinese large-scale pharmaceutical enterprises have devoted themselves to research and development…

BiosimilarsBiotechnologyChinaHengrui MedicineMarkets & MarketingQilu PharmResearchShanghai Pharmaceuticals

Prescribing habits for biosimilars will depend on robust clinical trials and manufacturer reputation

Prescribing habits for biosimilars will depend on robust clinical trials and manufacturer reputation

28-08-2014

Physicians across six different specialties expect that they will base prescribing decisions for biosimilars…

BiosimilarsBiotechnologyDecision Resources GroupMarkets & Marketing

Amgen and Novartis applauded for support of investor principles in biosimilar industry

Amgen and Novartis applauded for support of investor principles in biosimilar industry

12-08-2014

A coalition of institutional investors who have over $430 billion in assets has commended Amgen and Novartis…

AmgenBiosimilarBiosimilarsFinancialNovartisSandozUSA

FDA issues new biosimilars guidance on exclusivity

FDA issues new biosimilars guidance on exclusivity

11-08-2014

The US Food and Drug Administration has announced the availability of a draft guidance for industry titled…

BiosimilarsBiotechnologyFinancialRegulationUSA

US Senators call for immediate release of guidance on biosimilar drugs

US Senators call for immediate release of guidance on biosimilar drugs

06-08-2014

US Senators Lamar Alexander (Republican, Tennessee) and Orrin Hatch (Rep, Utah) have led colleagues in…

BiosimilarsGenericsPoliticsRegulationUS Food and Drug AdministrationUSA

Harlan aims to provide expertise for biologics and biosimilars

31-07-2014

Switzerland-based Harlan Laboratories, a privately held provider of general and specialty toxicology…

BiosimilarsBiotechnologyContract research servicesHarlanRegulationResearchSwitzerlandToxicology services

Sandoz application for biosimilar Neupogen accepted by US FDA

25-07-2014

The US Food and Drug Administration has accepted the Biologics License Application for filgrastim, which…

AmgenBiosimilarsBiotechnologyFilgrastimNeupogenNovartisOncologyRegulationSandozUSAZarzio

1 to 25 of 105 results

Back to top